{"article_id": "IVC_q3_2020.txt", "article": ["on the balance sheet , we retired a significant majority of the 2021 convertible notes , leaving just over $ 1 million maturing in february of next year .", "additionally , adjusted ebitda improved year - over - year and grew nearly 50 % sequentially , driven by higher net sales and lower sg&a expenses .", "with 95 % of our sales in northern hemisphere , we anticipate continued elevated demand as winter weather forces more people indoors with pandemic blues occurring as a result .", "as a result , reported net sales in europe improved over 38 % sequentially , although still lower than third quarter 2019 .", "this consolidates operations across germany and is expected to generate approximately $ 5 million in annual cost savings beginning in 2021 .", "reported net sales declined 10.1 % , primarily due to lower sales of mobility and seating and lifestyle products , partially offset by growth in respiratory products .", "gross profit was lower by 40 basis points to 28.3 % due to unfavorable manufacturing variances as a result of the lower sales volume .", "to offset this , we were able to drive constant currency sg&a down 12.5 % or $ 7.8 million through reduced employment cost , lower commercial expenses and favorable foreign exchange .", "as a result , operating income improved by 21.2 % or $ 500,000 and adjusted ebitda was $ 9.8 million , up 2.5 % , including the benefit of reduced sg&a expenses .", "free cash flow usage was $ 1.8 million , unfavorable to the third quarter 2019 by $ 14.1 million due to working capital needed to support operating activities .", "sequentially , reported net sales increased 8 % and constant currency net sales increased 4.3 % , driven by higher sales of mobility and seating products , including a 30 % increase in europe .", "gross profit was lower by 60 basis points to 28.3 % due to unfavorable manufacturing variances as a result of lower sales volume and the expected mix of lower acuity products as elective care resumed .", "constant currency sg&a decreased 6 % or $ 3.4 million , driven by lower stock compensation expense , which is typically higher in the second and fourth quarters of the year .", "operating income improved by $ 5.2 million , and adjusted ebitda improved 48.7 % or $ 3.2 million , driven by higher net sales and lower sg&a expenses .", "as a result of the initial easing of public healthcare restrictions , constant currency sequential net sales increased by 8 % , driven by a 30.4 % increase in sales of mobility and seating products , reflecting an early rebound in demand , particularly in france .", "gross profit was 230 basis points lower due to the reduced net sales and unfavorable manufacturing variances , both impacted by the pandemic , which affected sales volume and product mix .", "operating income was lower by $ 3.8 million due to reduced gross profit from lower net sales , partially offset by actions reducing sg&a expenses , such as furloughs and reduced work hours .", "constant currency net sales increased 1.2 % , with growth in respiratory products partially offset by lower sales of mobility and seating and lifestyle products .", "sequentially , constant currency net sales of mobility and seating products increased 0.2 % .", "gross profit increased 170 basis points or $ 2.6 million , driven by higher net sales and lower material and freight costs from prior transformation initiatives , partially offset by unfavorable variances and higher warranty expense .", "operating income was $ 3 million , an improvement of $ 4.7 million , driven primarily by actions which lowered sg&a expense .", "turning to slide 13 , all other , which includes the sales of the asia - pacific region , decreased by 3.1 % on a constant currency basis , driven by lower sales of mobility and seating products , partially offset by higher sale of lifestyle products .", "operating loss increased by $ 500,000 due to lower operating profit as a result of the dynamic control divestiture in the first quarter 2020 and improved $ 1.6 million sequentially , primarily driven by lower stock compensation expense .", "as of september 30 , 2020 , the company had total debt of $ 273 million , excluding operating and finance lease obligations .", "as of september 30 , 2020 , the company had $ 87 million of cash on its balance sheet , which was sequentially lower , primarily as a result of proactively repurchasing $ 24.5 million of convertible notes in the third quarter .", "we are pleased to have retired the significant majority of these notes , which increased our financial flexibility , reduced ongoing interest expense and leave a balance of less than $ 1.3 million maturing in february of 2021 .", "for the full year 2020 , the company now expects reported net sales of at least $ 840 million , up from the previous range of $ 810 million to $ 840 million , driven by the expected recovery of sales based on the recent trends we 've seen in the early part of the fourth quarter .", "adjusted ebitda in the range of $ 28 million to $ 32 million , up from the previous range of $ 27 million to $ 30 million due to the benefit of prior transformation actions and our continued ability to optimize cost .", "and free cash flow usage in the range of $ 8 million to $ 12 million , changed from the previous range of 7 % to 10 % , given the timing of the recognition of sales during the fourth quarter delaying the collection of cash into the first quarter of 2021 ."], "summary_gold": "increases full year 2020 guidance for net sales and adjusted ebitda .<q>sees fy 2020 reported net sales of at least $ 840 million , up from previous range of $ 810 to $ 840 million .<q>sees fy 2020 adjusted ebitda in the range of $ 28 to $ 32 million , up from previous range of $ 27 to $ 30 million .<q>sees fy 2020 free cash flow usage in the range of $ 8 to $ 12 million , changed from previous range of $ 7 to $ 10 million .", "summary_pred": "as a result , reported net sales in europe improved over 38 % sequentially , although still lower than third quarter 2019 .<q>gross profit increased 170 basis points or $ 2.6 million , driven by higher net sales and lower material and freight costs from prior transformation initiatives , partially offset by unfavorable variances and higher warranty expense .<q>adjusted ebitda in the range of $ 28 million to $ 32 million , up from the previous range of $ 27 million to $ 30 million due to the benefit of prior transformation actions and our continued ability to optimize cost .<q>this consolidates operations across germany and is expected to generate approximately $ 5 million in annual cost savings beginning in 2021 .<q>sequentially , constant currency net sales of mobility and seating products increased 0.2 % .<q>to offset this , we were able to drive constant currency sg&a down 12.5 % or $ 7.8 million through reduced employment cost , lower commercial expenses and favorable foreign exchange .<q>as of september 30 , 2020 , the company had total debt of $ 273 million , excluding operating and finance lease obligations .<q>on the balance sheet , we retired a significant majority of the 2021 convertible notes , leaving just over $ 1 million maturing in february of next year .", "len_article": 29, "len_summary_gold": 4, "len_summary_pred": 8, "len_sent_scores": 29}